Effective at the opening of trading on the Effective Date, the Company’s pre-consolidated common shares will be delisted from the Exchange and the post-consolidated common shares will commence trading ...

Discover how outsourcing regulatory submission content development improves efficiency and ensures compliance.

The "A Practical Approach to Developing the CMC Package for Veterinary Pharmaceutical Products Training Course" has been added to ResearchAndMarkets.com's offering. Understanding the chemistry, ...

Pharmaceutical consultants apply their comprehensive expertise in different areas to accelerate the drug development process.

CFO Joe Vazzano disclosed that Abeona had $98.1 million in cash and equivalents as of December 31, 2024, providing financial resources to fund operations into 2026 without considering potential pz-cel ...

Ladenburg, Germany, 21 March 2025 – Heidelberg Pharma AG (FSE: HPHA) today published its financial results and Annual Report for fiscal year 2024 (1 December 2023 – 30 November 2024) and its outlook ...

Cellogen Therapeutics’ CAR T cell technology introduces a bi-specific approach to cancer immunotherapy. Unlike conventional ...

30th Jan 2024 9:37 am RNS Director/PDMR Shareholding 16th Jan 2024 4:57 pm RNS Director/PDMR Shareholding 8th Jan 2024 10:43 am RNS Director/PDMR Shareholding 8th Jan 2024 7:00 am RNS Trading ...

This therapy targets multiple tumor-specific antigens, offering improved treatment precision for blood cancer patients, and ...